Presentation and Diagnosis of Hypersensitivity to Platinum Drugs

Evaluation of Basophil CD203c as a Predictor of Carboplatin-Related Hypersensitivity Reaction in Patients with Gynecologic Cancer

(2015) Takuya Iwamoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

(2014) Min Geun Lee et al.   CHEMOTHERAPY

Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil Mediators

(2014) Joana Caiado et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin

(2014) Quan Li et al.   GYNECOLOGIC ONCOLOGY

Oxaliplatin salvage for recurrent ovarian cancer: A single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity

(2014) Sarah E. Taylor et al.   GYNECOLOGIC ONCOLOGY

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer

(2014) Takahiro Yoneyama et al.   International Journal of Clinical Oncology

Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer

(2014) Masahiro Uchida et al.   International Journal of Clinical Oncology

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study

(2014) Naoto Takase et al.   International Journal of Clinical Oncology

Desensitization With Oxaliplatin in Patients Intolerant of Carboplatin Desensitization

(2014) Peter G. Rose et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma

(2014) Jessica L. Geiger et al.   ORAL ONCOLOGY

Hypersensitivity to oxaliplatin: clinical features and risk factors

(2014) Marie Parel et al.   BMC Pharmacology & Toxicology

Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review

(2014) Aleena Banerji et al.   Journal of Allergy and Clinical Immunology-In Practice

Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper

(2013) K. Brockow et al.   ALLERGY

Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment

(2013) R. Madrigal-Burgaleta et al.   ALLERGY

Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data

(2013) F. A. Raja et al.   ANNALS OF ONCOLOGY

Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and Chemotherapy

(2013) Veronica Mezzano et al.   BIODRUGS

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions

(2013) D H Moon et al.   BRITISH JOURNAL OF CANCER

Carboplatin-, Oxaliplatin-, and Cisplatin–specific IgE: Cross-reactivity and Value in the Diagnosis of Carboplatin and Oxaliplatin Allergy

(2013) Joana Caiado et al.   Journal of Allergy and Clinical Immunology-In Practice

Oxaliplatin Hypersensitivity: Evaluation, Implications of Skin Testing, and Desensitization

(2013) Johnson T. Wong et al.   Journal of Allergy and Clinical Immunology-In Practice

Hypersensitivity Reactions to Oxaliplatin: Clinical Features and Risk Factors in Koreans

(2012) Mi-Yeong Kim et al.   Asian Pacific Journal of Cancer Prevention

Immunology and Clinical Manifestations of Non-Clonal Mast Cell Activation Syndrome

(2012) Juan-Carlos Cardet et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Usefulness and Limitations of Sequential Serum Tryptase for the Diagnosis of Anaphylaxis in 102 Patients

(2012) Anna Sala-Cunill et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS

(2012) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations

(2012) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

An Experimental Biological Test to Diagnose Hypersensitivity Reactions to Carboplatin: New Horizons for an Old Problem

(2012) M. Pagani et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

(2012) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies

(2012) Hiroo Michikami et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Retreatment with nedaplatin in patients with recurrent gynecological cancer after the development of hypersensitivity reaction to carboplatin

(2012) Takahide Arimoto et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

A Retrospective Review of the Frequency and Nature of Acute Hypersensitivity Reactions at a Medium-Sized Infusion Center: Comparison to Reported Values and Inconsistencies Found in Literature

(2012) Patricia A. DeMoor et al.   Journal of Cancer

Desensitization regimens for drug allergy: state of the art in the 21st century

(2011) A. Liu et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial

(2011) Florence Joly et al.   GYNECOLOGIC ONCOLOGY

A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions

(2011) Sarita U. Patil et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer

(2011) Mette Sprauten et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study

(2011) R. I. Jakacki et al.   NEURO-ONCOLOGY

Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma

(2011) Dildar Bahar Genc et al.   SUPPORTIVE CARE IN CANCER

USEFULNESS OF SKIN TESTING WITH PLATINUM SALTS TO DEMONSTRATE LACK OF CROSS-REACTIVITY BETWEEN CARBOPLATIN AND CISPLATIN

(2010) Ernesto Enrique et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents

(2010) Christina Lee et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?

(2010) Ekaterini Syrigou et al.   ANTI-CANCER DRUGS

Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers

(2010) Hiroko Sugimoto et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Drug allergy

(2010) David A. Khan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Characteristics and Risk Factors of Oxaliplatin-related Hypersensitivity Reactions

(2010) Yu-Yun Shao et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX

(2010) Yukiko Mori et al.   ONCOLOGY

Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity

(2009) Ticha Limsuwan et al.   Expert Opinion On Drug Safety

Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management

(2009) Paul E. Hesterberg et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review

(2009) Brian H. Kim et al.   ONCOLOGY

Hypersensitivity reactions to oxaliplatin and other antineoplastic agents

(2008) Ekaterini Syrigou et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases

(2008) Mariana C. Castells et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clinical Features of Hypersensitivity Reactions to Oxaliplatin: A 10-Year Experience

(2008) Aristides Polyzos et al.   ONCOLOGY

Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma

(2007) Lucie Lafay-Cousin et al.   CANCER

Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer

(2007) A. GADDUCCI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER